berbamine has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Li, H; Luo, K; Wang, J; Wang, Q; Wu, D; Yang, X; Yang, Z; Ying, Y | 1 |
| Liu, B; Lu, X; Shu, Y; Zhang, B; Zhu, L | 1 |
2 other study(ies) available for berbamine and Stomach Neoplasms
| Article | Year |
|---|---|
Berbamine Suppresses the Growth of Gastric Cancer Cells by Inactivating the BRD4/c-MYC Signaling Pathway.
Topics: Benzylisoquinolines; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Humans; Molecular Docking Simulation; Signal Transduction; Stomach Neoplasms; Transcription Factors | 2022 |
Delivery of paclitaxel and berbamine by polymeric carriers to cure gastric cancer.
Topics: Animals; Antineoplastic Agents; Benzylisoquinolines; Cell Line, Tumor; Drug Carriers; Humans; Mice; Mice, Nude; Nanoparticles; Paclitaxel; Polyesters; Polyethylene Glycols; Stomach Neoplasms | 2013 |